Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Impact of microbiome manipulation on age-related inflammation and immune system dysfunction

Lauren Hillary Kodroff and Elizabeth B Norton
J Immunol May 1, 2016, 196 (1 Supplement) 214.22;
Lauren Hillary Kodroff
1Tulane Univ. Sch. of Med.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth B Norton
1Tulane Univ. Sch. of Med.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

The aging process can be described as a disease characterized by increasing inflammation and declining immune function. Gut microbiota may impact this process, as it is altered with both disease and advanced age. We examined if gut microbiota from young animals could reduce inflammation, cellular senescence, and immune system dysfunction in older animals. To do so, we performed fecal microbiota transplants (FMT) from young (14 weeks) to groups of young, middle-aged (50 weeks), and old (100 weeks) Balb/c mice. Groups (n=5) were pre-treated with ampicillin for 3 weeks followed by oral gavage with freshly homogenized fecal material (FMT groups) or PBS and euthanized 3 weeks later. Fecal samples were collected over time for microbial analyses. Small intestines, cecum, and colons were collected for gross and microscopic analyses. To examine changes to systemic immunity, splenic and whole blood B- and T-cells were stained for surface and intracellular marker expression (i.e. activation levels, senescence) by flow cytometry.

Overall, PBS control groups showed classic age-related effects. This included signs of molecular dysfunction in oldest mice with altered levels of the NfkB inhibitor IkBz and increased senescence subsets (P16INK4a+, β-gal+). A single FMT treatment had the most dramatic effects vs. PBS controls in older mice compared to other age groups. While treatment significantly reduced IkBz and microbial-sensing TLR2 expression, FMT did not have visible impact on cellular senescence. These results reinforce a critical role for the microbiome in age-related immune decline and suggest a regimen of FMT from healthy young subjects may be a potential strategy to lower chronic inflammation and improve immune function in the elderly.

  • Copyright © 2016 by The American Association of Immunologists, Inc.
Previous
Back to top

In this issue

The Journal of Immunology
Vol. 196, Issue 1 Supplement
1 May 2016
  • Table of Contents
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of microbiome manipulation on age-related inflammation and immune system dysfunction
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Impact of microbiome manipulation on age-related inflammation and immune system dysfunction
Lauren Hillary Kodroff, Elizabeth B Norton
The Journal of Immunology May 1, 2016, 196 (1 Supplement) 214.22;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Impact of microbiome manipulation on age-related inflammation and immune system dysfunction
Lauren Hillary Kodroff, Elizabeth B Norton
The Journal of Immunology May 1, 2016, 196 (1 Supplement) 214.22;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

  • Shortened T cell culture with IL-7 and IL-15 provides the most potent chimeric antigen receptor (CAR)-modified T cells for adoptive immunotherapy.
  • First generation CAR-T therapies can be rendered therapeutically effective when engineered into a novel human CD26high CD4+ T cell
  • CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Show more Immunotherapy 2

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606